← 治験一覧に戻る
FYU-981の単回投与第I相試験
基本情報
- NCT ID
- NCT02348307
- ステータス
- 完了
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 54
- 治験依頼者名
- Fuji Yakuhin Co., Ltd.
概要
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of FYU-981 administered orally to healthy male adults in fasted and fed conditions. Participants are randomized to placebo (n=3) or FYU-981 (n=6) in each step. After follow-up examination in the step of lower dose, the next dose is administered. The effect of food on PK/PD of FYU-981 is also investigated.
対象疾患
Healthy
介入
FYU-981, (Oral single dosing)(DRUG)
Placebo, (Oral single dosing)(DRUG)
依頼者（Sponsor）
株式会社富士薬品
(INDUSTRY)